from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3608c/folP1

LFCtreatmentdescriptionclass of inhibitor

-0.852

Amikacinug/mL Amikacintranslation

-2.295

Cap5-10ug/mL Capreomycintranslation

-1.353

Rox10-50 ug/mL Roxithromycintranslation

-0.524

SM2-5 ug/mL Streptomycintranslation

-0.796

Tet5-10 ug/mL Tetracyclinetranslation

-0.043

Rif0.2-5ug/mL Rifampicintranscription

-0.864

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.006

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.672

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.664

CPZ10-50 ug/mL Chlorpromazinerespiration

0.845

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.037

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.495

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.483

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.064

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.250

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.750

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.339

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.481

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.286

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.951

KCN5-20 ug/mL Potassium cyaniderespiration

-0.502

NaN30.2-2 mM Sodium aziderespiration

-0.203

Nigericin50 uM Nigericinrespiration

0.717

TRC10-150 ug/mL Triclosanrespiration

0.597

TRZ10-25 ug/mL Thioridazinerespiration

-0.573

Valinomycin0.5-10 uM Valinomycinrespiration

0.138

ZnSO42 mM ZnSO4respiration

-0.259

menadione6-10 ug/mL Menadionerespiration

0.072

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.104

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.573

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.198

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.108

NRP_1Non-replicating persistence stage 1dosRassociated

0.174

Amp0.2mg/mL AmpicillincellWall

-0.314

Cephalexin20-100 ug/mL CephalexincellWall

-0.475

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.313

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.094

EMB10-20 ug/mL EthambutolcellWall

0.024

Eta12-40 ug/mL EthionamidecellWall

-0.241

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.053

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.160

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.215

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.040

BZA0.12 mg/mL BenzamidearomaticAmides

-0.628

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.234

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.093

H2O24 mM hydrogen peroxideDNAdamaging

-0.729

Levo10 ug/mL LevofloxacinDNAdamaging

-0.253

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.906

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.566

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.235

UVUV-irradiationDNAdamaging

-0.172

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.544

Antimycin12.5-50 ug/mL Antimycin A?

-0.300

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.046

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.127

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.572

PA8240.2-2 ug/mL PA-824?

1.165

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.288

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.008

Verapamil50 uM Verapamil?

-0.394

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.731

methoxatin10-20 ug/mL Methoxatin?